John L. Higgins - Feb 15, 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role: Chief Executive Officer, Director
Signature: By: Charles S. Berkman For: John L. Higgins
Stock symbol: LGND
Transactions as of: Feb 15, 2022
Transactions value $: -$732,557
Form type: 4
Date filed: 2/16/2022, 07:23 PM
Previous filing: Jan 28, 2022
Next filing: May 9, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LGND	Common Stock	Tax liability	-$241K	-1.95K	-0.56%	$123.68	345K	Feb 15, 2022	Direct	F1
transaction	LGND	Common Stock	Tax liability	-$255K	-2.06K	-0.6%	$123.68	343K	Feb 15, 2022	Direct	F2
transaction	LGND	Common Stock	Tax liability	-$237K	-1.92K	-0.56%	$123.68	341K	Feb 15, 2022	Direct	F3

Showing 1 to 3 of 3 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/11/2019.
F2	Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/13/2020.
F3	Represents shares withheld to satisfy tax withholding obligations upon the vesting of previously reported restricted stock units that were granted on 02/03/2021.